CXCL12 and breast cancer: Overexpression of the inhibitor of nuclear factor kappa-B kinase (IKK) in breast cancer cells with constitutive NF-κB activity resulted in reduced expression of the receptor CXCR4 in vitro and the corresponding loss of migration mediated by its ligand, the SDF-1α.